PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
26.61
Positive P/E while Healthcare median is negative at -2.34. Peter Lynch would investigate competitive advantages in a distressed Healthcare.
3.56
P/S less than half the Healthcare median of 12.08. Walter Schloss would verify if this discount reflects fixable issues. Check margins versus peers.
5.10
P/B exceeding 1.5x Healthcare median of 3.26. Jim Chanos would check for potential asset write-down risks.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.10
Fair value ratio exceeding 1.5x Healthcare median of 3.26. Jim Chanos would check for valuation bubble risks.
0.94%
Positive earnings while Healthcare median shows losses. Peter Lynch would examine earnings quality advantage.
No Data
No Data available this quarter, please select a different quarter.